Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
Jason Litsky,1 Arijit Chanda,2 Erik Stilp,1 Alexandra Lansky,1 Carlos Mena11Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA; 2Section of Cardiology, Department of Internal Medicine, Bridgeport Hospital, Bridgeport, CT, USAA...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2219e177cd0a4cc6ac45eca9127605cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2219e177cd0a4cc6ac45eca9127605cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2219e177cd0a4cc6ac45eca9127605cf2021-12-02T08:47:30ZCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent1179-1470https://doaj.org/article/2219e177cd0a4cc6ac45eca9127605cf2014-05-01T00:00:00Zhttp://www.dovepress.com/critical-evaluation-of-stents-in-the-peripheral-arterial-disease-of-th-a17029https://doaj.org/toc/1179-1470 Jason Litsky,1 Arijit Chanda,2 Erik Stilp,1 Alexandra Lansky,1 Carlos Mena11Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA; 2Section of Cardiology, Department of Internal Medicine, Bridgeport Hospital, Bridgeport, CT, USAAbstract: The endovascular management of obstructive disease of the superficial femoral artery (SFA) is challenging due to unique anatomical and biomechanical forces. Obstructive lesions of the SFA make up the largest proportion of lesions leading to symptomatic peripheral arterial disease. Accordingly, endovascular treatment of SFA disease is becoming increasingly common and, in many cases, is the preferred initial therapy. The use of self-expanding nitinol stents have proven superior to percutaneous transluminal balloon angioplasty in the treatment of intermediate length SFA stenosis. However, achieving durable results, as well as attaining adequate therapy for long occlusions typically seen in clinical practice, remains problematic. Newer technologies, such as paclitaxel eluting stents, seem promising in improving outcomes.Keywords: Zilver PTX, self-expanding stent, atherosclerotic disease, superficial femoral arteryLitsky JChanda AStilp ELansky AMena CDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2014, Iss default, Pp 149-156 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medical technology R855-855.5 |
spellingShingle |
Medical technology R855-855.5 Litsky J Chanda A Stilp E Lansky A Mena C Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
description |
Jason Litsky,1 Arijit Chanda,2 Erik Stilp,1 Alexandra Lansky,1 Carlos Mena11Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA; 2Section of Cardiology, Department of Internal Medicine, Bridgeport Hospital, Bridgeport, CT, USAAbstract: The endovascular management of obstructive disease of the superficial femoral artery (SFA) is challenging due to unique anatomical and biomechanical forces. Obstructive lesions of the SFA make up the largest proportion of lesions leading to symptomatic peripheral arterial disease. Accordingly, endovascular treatment of SFA disease is becoming increasingly common and, in many cases, is the preferred initial therapy. The use of self-expanding nitinol stents have proven superior to percutaneous transluminal balloon angioplasty in the treatment of intermediate length SFA stenosis. However, achieving durable results, as well as attaining adequate therapy for long occlusions typically seen in clinical practice, remains problematic. Newer technologies, such as paclitaxel eluting stents, seem promising in improving outcomes.Keywords: Zilver PTX, self-expanding stent, atherosclerotic disease, superficial femoral artery |
format |
article |
author |
Litsky J Chanda A Stilp E Lansky A Mena C |
author_facet |
Litsky J Chanda A Stilp E Lansky A Mena C |
author_sort |
Litsky J |
title |
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
title_short |
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
title_full |
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
title_fullStr |
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
title_full_unstemmed |
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
title_sort |
critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent |
publisher |
Dove Medical Press |
publishDate |
2014 |
url |
https://doaj.org/article/2219e177cd0a4cc6ac45eca9127605cf |
work_keys_str_mv |
AT litskyj criticalevaluationofstentsintheperipheralarterialdiseaseofthesuperficialfemoralarteryndashfocusonthepaclitaxelelutingstent AT chandaa criticalevaluationofstentsintheperipheralarterialdiseaseofthesuperficialfemoralarteryndashfocusonthepaclitaxelelutingstent AT stilpe criticalevaluationofstentsintheperipheralarterialdiseaseofthesuperficialfemoralarteryndashfocusonthepaclitaxelelutingstent AT lanskya criticalevaluationofstentsintheperipheralarterialdiseaseofthesuperficialfemoralarteryndashfocusonthepaclitaxelelutingstent AT menac criticalevaluationofstentsintheperipheralarterialdiseaseofthesuperficialfemoralarteryndashfocusonthepaclitaxelelutingstent |
_version_ |
1718398351090647040 |